跳至主要内容
临床试验/NCT03137719
NCT03137719已完成不适用

Infections and Other Complications of Cirrhosis: A Prospective Multi-Center Study

Baylor Research Institute0 个研究点目标入组 385 人开始时间: 2011年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
385
主要终点
Patterns and adequacy of albumin use in infected and non-infected patients

研究概览

简要总结

Hospitalized cirrhotic patients are at high risk of complications and adverse outcomes. This study aims to determine the current practice and outcomes in these following areas:

  1. Community-acquired infections
  2. Nosocomial infections
  3. Development of second infections
  4. Factors predicting ICU care, organ failure, death, and disability
  5. Patterns and adequacy of albumin use in infected and non-infected patients
  6. Per and post-liver transplant outcomes
  7. Quality-assurance and adequacy of management of complications of cirrhosis such as hepatic encephalopathy, variceal bleeding, hyponatremia, and hypernatremia
  8. Regional variations in outcomes and therapeutic strategies

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male and Female over 18 years of age
  • Cirrhosis as diagnosed by either liver histology or a combination of clinical biochemical (low platelets, elevated bilirubin, and/or INR, low albumin) radiologic (nodular liver on ultrasound) and endoscopic (esophageal varices) criteria
  • Subject must be able to understand and provide informed consent
  • Evaluated in the ER or admitted to the hospital for non-elective reasons

排除标准

  • admitted for elective purpose

结局指标

主要结局

Patterns and adequacy of albumin use in infected and non-infected patients

时间窗: From admission to 1 year post-discharge from the hospital

IV albumin administration

Regional variations in outcomes and therapeutic strategies

时间窗: From admission to 1 year post-discharge from the hospital

Comparison of data between sites conducting this study across the United States and Canada

Frequency, Cause and Outcome of Community-acquired infections

时间窗: From admission to 1 year post-discharge from the hospital

Collecting details of infections including type, organism, antibiotic used, length of stay, ICU stay and outcomes

Frequency, Cause, and Outcome of Nosocomial infections

时间窗: From admission to 1 year post-discharge from the hospital

Collecting details of infections including type, organism, antibiotic used, length of stay, ICU stay and outcomes

Development of second infections

时间窗: From admission to 1 year post-discharge from the hospital

Distinctly different from primary infection

Factors predicting ICU care, organ failure, death, and disability

时间窗: From admission to 1 year post-discharge from the hospital

Admission to the ICU and events/outcomes of that subject's admission

Quality-assurance and adequacy of management of complications of cirrhosis such as hepatic encephalopathy, variceal bleeding, hyponatremia, and hypernatremia

时间窗: From admission to 1 year post-discharge from the hospital

Blood test and other obvious clinical evidence of decompensation

Peri and post-liver transplant outcomes based on physiological parameters

时间窗: From admission to 1 year post-discharge from the hospital

Collection of liver transplant donor and recipient information such as blood group, CMV status, post-transplant infections, immunosuppression regimen, and prophylaxis given.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验

Infections in Hospitalized Cirrhotic Patients | 临床试验